Multimodal treatment of hepatocellular carcinoma: An eastern European experience

Hepato-Gastroenterology

Volumn 56, Issue 96, 2009, Pages 1696-1703

  Dima, Simona Olimpia ^a   Iacob, Speranţa ^a   Botea, Florin ^b,c   Matei, Emil ^a   Dorobanţu, Bogdan ^a   Vasile, Şerban ^a   Alexandrescu, Sorin ^a   Croitoru, Adina ^a   Dumitraşcu, Traian ^a   Stroescu, Cezar ^a   Herlea, Vlad ^a   Popescu, Irinel ^a  

^a FUNDENI CLINICAL INSTITUTE   (Romania)

^b OVIDIUS UNIVERSITY   (Romania)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Hepatocellular carcinoma; Multimodal treatment; Predictive factors

Indexed keywords

ALPHA FETOPROTEIN; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHILD; CONTROLLED STUDY; EUROPE; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY ABLATION; RECURRENCE RISK; SCHOOL CHILD; TERTIARY HEALTH CARE; TREATMENT OUTCOME; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CHILD; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 74949144512     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108.
2. Sangiovanni A, Del NE, Fasani P, et al: Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 2004; 126:1005-1014.
3. Bosch FX, Ribes J, Diaz M, Cleries R: Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127:S5-S16.
4. Fattovich G, Giustina G, Realdi G, et al: Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfa. European Concerted Action on Viral Hepatitis (EUROHEP). Hepatology 1997; 26:1338-1342.
5. Llovet JM: Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 2005; 40:225-235.
6. Ishizaki Y, Kawasaki S: The evolution of liver transplantation for hepatocellular carcinoma (past, present, and future). J Gastroenterol 2008; 43:18-26.
7. Fattovich G, Stroffolini T, Zagni J, Donato F: Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004; 127:S35-S50.
8. Huang YH, Wu JC, Chau GY, et al: Supportive treatment, resection and transcatheter arterial chemoembolization in resectable hepatocellular carcinoma: an analysis of survival in 419 patients. Eur J Gastroenterol Hepatol 1999; 11:315-321.
9. Bigourdan JM, Jaeck D, Meyer N, et al: Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl 2003; 9:513-520.
10. Majno PE, Sarasin FP, Mentha G, Hadengue A: Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis. Hepatology 2000; 31:899-906.
11. Takano S, Watanabe Y, Ohishi H, et al: Multimodality treatment for patients with hepatocellular carcinoma: a single institution retrospective series. Eur J Surg Oncol 2000; 26:67-72.
12. Otto G, Heuschen U, Hofmann WJ, et al: Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis. Ann Surg 1998; 227:424-432.
13. Dharancy S, Boitard J, Decaens T, et al: Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control study. Liver Transpl 2007; 13:665-671.
14. Chen MS, Li JQ, Zheng Y, et al: A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006; 243:321-328.
15. Edmondson HA, Steiner PE: Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954; 7:462-503.
16. Green FL, Page DL, Fleming ID: "AJCC cancer staging manual." Chicago: Springer, 2002.
17. The Cancer of the Liver Italian Program (CLIP) investigators: A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 1998; 28:751-755.
18. Kudo M, Chung H, Osaki Y: Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol 2003; 38:207-215.
19. Okuda K, Ohtsuki T, Obata H, et al: Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985; 56:918-928.
20. Vauthey JN, Lauwers GY, Esnaola NF, et al: Simplified staging for hepatocellular carcinoma. J Clin Oncol 2002; 20:1527-1536.
21. Mazzaferro V, Regalia E, Doci R, et al: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334:693-699.
22. Popescu I, Simionescu M, Tulbure D, et al: Homozygous familial hypercholesterolemia: specific indication for domino liver transplantation. Transplantation 2003; 76:1345-1350.
23. Popescu I: Living donor liver transplantation for hepatocellular carcinoma: defining criteria to extend indications. Dig Dis Sci 2009; 54:199-200.
24. Popescu I, Sirbu-Boeti MP, Tomulescu V, et al: (Therapy of malignant liver tumors using microwave and radiofrequency ablation). Chirurgia (Bucur ) 2005; 100:111-120.
25. Gheorghe L, Iacob S, Iacob R, et al: Variation of the MELD score as a predictor of death on the waiting list for liver transplantation. J Gastrointestin Liver Dis 2007; 16:267-272.
26. Gheorghe L, Iacob S, Csiki IE: Prevalence of hepatitis C in Romania: different from European rates? J Hepatol 2008; 49:661-662.
27. Sasaki Y, Yamada T, Tanaka H, et al: Risk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis B- or hepatitis C-related hepatocellular carcinoma. Ann Surg 2006; 244:771-780.
28. Scatton O, Zalinski S, Terris B, et al: Hepatocellular carcinoma developed on compensated cirrhosis: resection as a selection tool for liver transplantation. Liver Transpl 2008; 14:779-788.
29. Perry JF, Charlton B, Koorey DJ, et al: Outcome of patients with hepatocellular carcinoma referred to a tertiary centre with availability of multiple treatment options including cadaveric liver transplantation. Liver Int 2007; 27:1240-1248.
30. Bismuth H, Chiche L, Castaing D: Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: experience with 68 liver resections. World J Surg 1995; 19:35-41.
31. Imamura H, Matsuyama Y, Miyagawa Y, et al: Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma. Br J Surg 1999; 86:1032-1038.
32. Cucchetti A, Piscaglia F, Caturelli E, et al: Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. Ann Surg Oncol 2009; 16:413-422.
33. Poon RT, Fan ST, Ng IO, et al: Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 2000; 89:500-507.
34. Lee SG, Hwang S, Jung JP, et al: Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions. Br J Surg 2007; 94:320-326.
35. Capussotti L, Ferrero A, Vigano L, et al: Liver resection for HCC with cirrhosis: surgical perspectives out of EASIVAASLD guidelines. Eur J Surg Oncol 2009; 35:11-15.
36. Pandey D, Lee KH, Wai CT, et al: Long term outcome and prognostic factors for large hepatocellular carcinoma (10cm or more) after surgical resection. Ann Surg Oncol 2007; 14:2817-2823.
37. Wakai T, Shirai Y, Suda T, et al: Long-term outcomes of hepatectomy vs percutaneous ablation for treatment of hepatocellular carcinoma < or =4cm. World J Gastroenterol 2006; 12:546-552.
38. Chen MS, Li JQ, Zheng Y, et al: A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006; 243:321-328.
39. Kooby DA, Egnatashvili V, Graiser M, et al: Changing management and outcome of hepatocellular carcinoma: evaluation of 501 patients treated at a single comprehensive center. J Surg Oncol 2008; 98:81-88.
40. Poon RT, Fan ST, Loem, et al: Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival. Ann Surg 2007; 245:51-58.
41. Gondolesi GE, Roayaie S, Munoz L, et al: Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg 2004; 239:142-149.
42. Sugawara Y, Tamura S, Makuuchi M: Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Dig Dis 2007; 25:310-312.
43. Heckman JT, Devera MB, Marsh JW, et al: Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation. Ann Surg Oncol 2008; 15:3169-3177.
44. Shimada K, Sakamoto Y, Esaki M, et al: Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 2007; 14:2337-2347.
45. Kamath PS, Wiesner RH, Malinchoc M, et al: A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464-470.
46. Mazzaferro V, Battiston C, Perrone S, et al: Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg 2004; 240:900-909.
47. Tateishi R, Shiina S, Ohki T, et al: Treatment strategy for hepatocellular carcinoma: expanding the indications for radiofrequency ablation. J Gastroenterol 2009; 44 Suppl 19:142-146.
48. Torzilli G, Donadon M, Marconi M, et al: Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification: results of a prospective analysis. Arch Surg 2008; 143:1082-1090.
49. Nouso K, Matsumoto E, Kobayashi Y, et al: Risk factors for local and distant recurrence of hepatocellular carcinomas after local ablation therapies. J Gastroenterol Hepatol 2008; 23:453-458.
50. Zou WL, Zang YJ, Chen XG, Shen ZY: Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation. Hepatobiliary Pancreat Dis Int 2008; 7:145-151.
51. Strasberg SM: Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg 2005; 12:351-355.